82
Views
59
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo antitumoral activity of free, and encapsulated taxol

, , , , , & show all
Pages 191-197 | Received 19 Jul 1989, Accepted 04 Aug 1989, Published online: 27 Sep 2008
 

Abstract

The anti-tumoral activity of taxol encapsulated either in liposomes or in nanocapsules was compared with that of free taxol, using the P388 and L1210 leukaemia test systems. The in vitro inhibition of cell growth was measured after 48 h and 96 h exposure to various concentrations of taxol. With P388 cells, the inhibitory activities of the three forms of the drug were similar. With the L1210 cells, however, the concentrations required for a 50 per cent inhibition of cell growth (IC50) after 48 h exposure to the drug were greater for nanocapsules than for liposomes or free taxol, the values being 0·060, 0·043 and 0·035 μg ml−1, respectively. However, a greater efficiency of nanocapsules was observed after 96 h exposure. Using cytomorphometric analysis, no difference was found between L1210 cells treated either with free or encapsulated taxol. In vivo, mice bearing P388 leukaemia, and treated either with taxol solubilized with 5 per cent DMSO+5 per cent cremophor in saline solution, or with taxol encapsulated in liposomes (IP daily dose of 12·5 mg Kg−1 body weight · 4 days) showed ILS values of 65·8% and 67·9% respectively. Nanocapsules proved to be toxic, apparently due to their composition: this problem is currently under investigation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.